Table 3.
Results of the MMPI-2-RF Higher-Order and Restructured Clinical Scales of patients with Noonan syndrome (NS, n = 18) and healthy controls (HC, n = 18)
| MMPI-2-RF H-O and RC scales | Median raw score (range) | Mean uniform or linear T-scores (SD) | U | z | p | r | ||
|---|---|---|---|---|---|---|---|---|
| NS | HC | NS | HC | |||||
| EID | 17.5 (2–36) | 9 (4–34) | 61.56 (13.72) | 53.44 (10.77) | 99.00 | − 2.00 | .05 | − .33 |
| THD | 3 (0–8) | 1.5 (0–7) | 53.72 (11.47) | 52.89 (10.69) | 154.50 | − .24 | .82 | − .04 |
| BXD | 3.5 (0–15) | 3.5 (0–14) | 54.17 (17.35) | 57.00 (14.97) | 184.00 | .70 | .50 | .12 |
| RCd | 10 (0–23) | 2 (0–20) | 63.78 (13.21) | 52.44 (11.71) | 83.50 | − 2.49 | .01 | − .42 |
| RC1 | 8.5 (0–21) | 6.5 (3–14) | 64.72 (18.16) | 57.83 (8.51) | 123.00 | − 1.24 | .23 | − .21 |
| RC2 | 8 (2–12) | 6 (2–13) | 55.50 (9.62) | 51.94 (8.76) | 120.00 | − 1.34 | .19 | − .22 |
| RC3 | 4 (0–14) | 6.5 (0–11) | 47.28 (14.42) | 50.11 (9.25) | 206.00 | 1.40 | .17 | .23 |
| RC4 | 4 (0–18) | 2 (0–10) | 61.89 (18.26) | 56.11 (14.26) | 129.00 | − 1.05 | .31 | − .18 |
| RC6 | 3 (0–10) | 2 (0–6) | 58.94 (14.72) | 56.17 (9.32) | 134.50 | − .89 | .39 | − .15 |
| RC7 | 7.5 (0–16) | 5.5 (1–16) | 57.72 (13.94) | 55.78 (11.53) | 144.00 | − .57 | .58 | − .10 |
| RC8 | 2 (0–5) | 2 (0–9) | 52.22 (10.76) | 54.33 (11.83) | 168.00 | .19 | .86 | .03 |
| RC9 | 7.5 (0–19) | 10.5 (1–20) | 49.50 (14.46) | 54.67 (12.62) | 198.00 | 1.14 | .27 | .19 |
H-O Higher-Order, RC Restructured Clinical, EID Emotional/Internalizing Dysfunction, THD Thought Dysfunction, BXD Behavioural/Externalizing Dysfunction, RCd Demoralization, RC1 Somatic Complaints, RC2 Low Positive Emotions, RC3 Cynism, RC4 Antisocial Behaviour, RC6 Ideas of Persecution, RC7 Dysfunctional Negative Emotions, RC8 Aberrant Experiences, RC9 Hypomanic Activation, U Mann–Whitney’s U statistic, z z-score, r effect size estimate